News

This partnership sets out to explore new avenues of medical research and drug discovery across a broad range of diseases, with a view to achieving breakthroughs in the understanding of human disease.

A study led by OHSU researchers has revealed a critical first step in developing a new gene and stem cell regenerative technique for treating patients with mitochondrial disease.

Researchers have developed a network for describing protein-protein interactions that can then be used to examine protein interactions that may have biological or clinical significance.

An international team of scientists has announced that a new compound to fight malaria is ready for human trials.

TAU researcher finds non-psychotropic compound in marijuana can help heal bone fissures.

Company acquires drug products from Teva Pharmaceuticals for $25 million in cash.

New partnership expands commercialization footprint for low dose NSAID.

Company earns milestone payment from Biogen for advancing ISIS-SMN Rx in children with SMA.

The drug prevents cancer progression and paves the way for new advancements in cancer therapeutics.

Dr. Fiona Withey, Managing Director UK Clinical Services, first ever female executive to join the expert panel.